Codice QR

Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain

Background: The prevalence of chronic conditions that increase the risk of influenza complications is high among individuals aged ≥50 years, and evidence suggests age-related changes in immune responses to vaccines begin to decline at this age. Persons aged 50–59 years have high rates of influenza i...

Descrizione completa

Salvato in:
Autori principali: Alberto Perez-Rubio, Roberto Flores, Jesus Ruiz Aragon, Javier Sanchez, Sergio Marquez-Peláez, Piedad Alvarez, Andres Osorio Muriel, Joaquin Mould-Quevedo
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2025-03-01
Serie:Vaccines
Soggetti:
influenza
vaccination
Spain
cost-effectiveness
adjuvanted
high-dose
Accesso online:https://www.mdpi.com/2076-393X/13/3/323
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi